Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Renal Insufficiency × Dexamethasone × Clear all

Phase

Phase 2 10 Phase EARLY_PHASE1 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 116 Recurrence 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Neoplasms, Plasma Cell 14 Neoplasms 12 Lymphoma, Non-Hodgkin 10 Lymphoma 10 Leukemia, Myeloid, Acute 10 Neoplasm Metastasis 8 Leukemia 8 Lymphoma, Large B-Cell, Diffuse 6 Burkitt Lymphoma 6 Prostatic Neoplasms 5 Hodgkin Disease 5 Leukemia, Biphenotypic, Acute 4 Immunoglobulin Light-chain Amyloidosis 4 Waldenstrom Macroglobulinemia 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, T-Cell, Cutaneous 3 Lymphoma, T-Cell 3 Lymphoma, B-Cell 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Colorectal Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Sarcoma 2 Rectal Neoplasms 2 Plasmacytoma 2 Paraproteinemias 2 Oligodendroglioma 2 Myelodysplastic Syndromes 2

Interventions

Kidney Transplantation 2 Cyclophosphamide 2 Azacitidine 2 trifluridine tipiracil drug combination 1 trebananib 1 safinamide 1 sacubitril and valsartan sodium hydrate drug combination 1 rubitecan 1 ripretinib 1 regorafenib 1 pomalidomide 1 pevonedistat 1 mirabegron 1 glucarpidase 1 gamma-Glutamyl Hydrolase 1 dabrafenib 1 copanlisib 1 belinostat 1 belantamab mafodotin 1 Whole-Body Irradiation 1 Topotecan 1 Sitagliptin Phosphate 1 Rituximab 1 Pharmacogenomic Testing 1 Paclitaxel 1 Oxaliplatin 1 Methotrexate 1 Leucovorin 1 Duration of Therapy 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01575925 2022-11-04

POM Renal

Celgene

Phase 1 Completed

Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡